PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) announced that the Opposition Division of the European Patent Office decided at an oral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE